Henan Taloph Pharmaceutical Stock Co.,Ltd. Posted 24.2 Million Yuan Net Loss in First Half of 2022

Henan Taloph Pharmaceutical Stock Co.,Ltd. (河南太龙药业股份有限公司) (600222.SH) reported a net loss of 24.2 million yuan in the first half of 2022, reversing a net profit of 28 million yuan for the same period in the previous year.

Meanwhile, the company posted 863.7 million yuan in revenue, up 14.9% year-on-year.

At the end of the reporting period, it had 3.5 billion yuan in total assets and 1.7 billion yuan in total liabilities, with a liability-to-asset ratio of 48.8%.